Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12180196-B2 · Dec 31, 2024 · US
Stable solid pharmaceutical matrix compositions of sirolimus
US9101541B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9101541-B2 |
| Application number | US-201113643386-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 25, 2011 |
| Priority date | Apr 28, 2010 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention discloses a stable solid pharmaceutical matrix composition comprising sirolimus or pharmaceutically acceptable salts thereof along with one or more sugars.
First claim
Opening claim text (preview).
We claim: 1. A stable solid pharmaceutical matrix composition comprising sirolimus or a pharmaceutically acceptable salt thereof along with one or more sugars selected from sucrose, dextrose, fructose, mannitol, xylitol and sorbitol, wherein the sugar is present in the matrix in an amount of 31.55% by weight of total composition and wherein the sirolimus or a pharmaceutically acceptable salt thereof have a D 90 particle size of less than about 10 μm. 2. The sta…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K9/2866Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9101541B2 cover?
- The present invention discloses a stable solid pharmaceutical matrix composition comprising sirolimus or pharmaceutically acceptable salts thereof along with one or more sugars.
- Who is the assignee on this patent?
- Roy Sunilendu Bhushan, Kulkarni Sushrut Krishnaji, Panchal Kiritkumar Maulik, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K9/2866. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).